PofoliaShared via Pofolia

Folia Microbiologica· 2025Q2

Microbiota-based therapies in oral health and disorders

Akram N. Salah, Youssef A Doghish, Shaimaa O Abbass, Reda M. Mansour et al.

Short summary

Microbiome-based therapies, including probiotics (e.g., Streptococcus salivarius), postbiotics, predatory bacteria (e.g., Bdellovibrio bacteriovorus), and bacteriophages, show promise in restoring oral microbial balance and combating diseases like periodontitis by selectively eliminating pathogens or modulating host immunity.

AI-generated from the title and abstract; the full text is not read.

Key points

  • Oral dysbiosis is a key driver of diseases such as dental caries and periodontal disease.
  • Probiotics (e.g., Streptococcus salivarius) and postbiotics can reduce plaque, gingival inflammation, and pathogenic bacteria.
  • Predatory bacteria (e.g., Bdellovibrio bacteriovorus) and bacteriophages offer precision targeting and elimination of oral pathogens.
  • Microbiota-based therapies aim to restore microbial balance and modulate host immune responses for sustainable oral health.

AI-generated from the title and abstract; the full text is not read.

Abstract

The human oral microbiome is a complex, dynamic ecosystem critically involved in maintaining oral health and contributing to systemic well-being. Many bacteria and fungi are involved in oral cavities such as Penicillium, Rhodotorula, Saccharomycetales, Streptococcus, Veillonella, Neisseria, Actinomyces, and Schizophyllum. Disruption of microbial homeostasis, or dysbiosis, underpins a wide spectrum of oral diseases, including dental caries, periodontal disease, endodontic infections, and mucosal conditions. Recent advances in microbiome research have elucidated the mechanisms by which pathogenic microbial consortia, such as the red complex (Porphyromonas gingivalis, Tannerella. forsythia, and Treponema denticola), synergistically promote disease progression through virulence factors, metabolic interactions, and biofilm formation. Emerging microbiome-based therapies, comprising probiotics, postbiotics, predatory bacteria, and using bacteriophages, offer promising adjuncts or alternatives to traditional antimicrobial approaches by restoring microbial balance, reducing pathogenic load, and modulating host immune responses. For instance, probiotic strains like Streptococcus salivarius and Lactobacillus spp. have demonstrated efficacy in reducing plaque, gingival inflammation, and pathogenic bacteria, as well as having significant immunological modulation, while postbiotics provide similar benefits with enhanced safety and stability. Additionally, predatory bacteria such as Bdellovibrio bacteriovorus show potential for selective bacterial elimination and combating periodontal diseases that are driven by Gram-negative anaerobes. Bacteriophages offer another precision tool for targeting oral pathogens by lysing bacteria upon replication. Finally, oral microbiota transplantation aimed at treating periodontal disease by restoring a balanced microbial community in the oral cavity. These innovative strategies, combined with a nuanced understanding of biofilm dynamics and host-microbe interactions, pave the way for personalized and ecologically sustainable oral health interventions. Continued research is essential to translate these promising approaches into clinical practice, optimize delivery systems, and elucidate long-term safety and efficacy.

The authors' abstract, as published at the source. Folia Microbiologica, 2025 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Periodontics

PeriodonticsDentistry